Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Dan Cooper is not surprised by the popularity of injectable GLP-1 weight loss drugs, he tells Science News Explores that hes worried about their long-term safety, especially when it comes to those under 18
Retatrutide is a once-weekly subcutaneous peptide that simultaneously activates GIP, GLP-1, and glucagon receptors
Thanks to this, it can be taken at any time, regardless of meals or time of day, making it easier for patients to adhere to the regimen
Those with untreated or poorly controlled thyroid disease need endocrinology evaluation before starting, since semaglutide's effects on metabolism interact with thyroid function
